ReviewTherapeutic advances in medical oncology2024

Antibody drug conjugates in recurrent or metastatic cervical cancer: a focus on tisotumab vedotin state of art.

Floriana Camarda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.